Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ADVISORY, Oct. 31, 2016 (GLOBE NEWSWIRE) -- What: New York Startup CTO Summit will visit the Nasdaq MarketSite in Times Square to kick off the 2nd annual event on November 1. In honor...
-
ADVISORY, Oct. 31, 2016 (GLOBE NEWSWIRE) -- What: Insulet Corporation (Nasdaq:PODD), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management...
-
SIX to leverage Nasdaq’s trading, market surveillance and pre-trade risk management technologies SIX dark pool in development to be powered and surveilled by Nasdaq technology NEW YORK and...
-
NEW YORK, Oct. 28, 2016 (GLOBE NEWSWIRE) -- Quantenna Communications, Inc. (Nasdaq:QTNA), a provider of high-performance Wi-Fi solutions, visited the Nasdaq MarketSite in Times Square today in...
-
ADVISORY, Oct. 28, 2016 (GLOBE NEWSWIRE) -- What: Exchange Traded Concepts, Loncar Investments, and Cancer Research Institute will visit the Nasdaq MarketSite in Times Square to celebrate...
-
NEW YORK, Oct. 28, 2016 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq:BL), a leading provider of financial controls and automation software that enable Continuous Accounting, visited the Nasdaq...
-
ADVISORY, Oct. 28, 2016 (GLOBE NEWSWIRE) -- What:Youth INC, a nonprofit organization that aims to transform the lives of NYC kids through our unique venture philanthropy model that empowers the...
-
ADVISORY, Oct. 28, 2016 (GLOBE NEWSWIRE) -- What: BlackLine, Inc. (Nasdaq: BL), a leading provider of financial controls and automation solutions that enable Continuous Accounting, will...
-
ADVISORY, Oct. 28, 2016 (GLOBE NEWSWIRE) -- What:Quantenna Communications, Inc. (Nasdaq:QTNA), a provider of high-performance Wi-Fi solutions, will visit the Nasdaq MarketSite in Times Square in...
-
NEW YORK, Oct. 27, 2016 (GLOBE NEWSWIRE) -- Ra Pharmaceuticals Inc. (Nasdaq:RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for diseases...